These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31126901)

  • 1. Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS).
    Gold LS; Patrick DL; Hansen RN; Goss CH; Kessler L
    J Cyst Fibros; 2019 Nov; 18(6):886-893. PubMed ID: 31126901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correspondence between symptoms and preference-based health status measures in the STOP study.
    Gold LS; Patrick DL; Hansen RN; Beckett V; Goss CH; Kessler L
    J Cyst Fibros; 2019 Mar; 18(2):251-264. PubMed ID: 30170756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale.
    Gill ER; Goss CH; Sagel SD; Wright ML; Horner SD; Zuñiga JA
    BMC Pulm Med; 2024 Jul; 24(1):360. PubMed ID: 39049032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis.
    VanDevanter EJ; Heltshe SL; Skalland M; Lechtzin N; Nichols D; Goss CH
    J Cyst Fibros; 2021 Nov; 20(6):932-936. PubMed ID: 33685776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis.
    Ye SC; Desai S; Karlsen E; Kwong E; Wilcox PG; Quon BS
    J Cyst Fibros; 2022 Nov; 21(6):1048-1052. PubMed ID: 35370086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale.
    Gill ER; Goss CH; Sagel SD; Wright ML; Horner SD; Zuñiga JA
    Res Sq; 2023 Sep; ():. PubMed ID: 37790510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.
    Wagener JS; VanDevanter DR; Konstan MW; Pasta DJ; Millar SJ; Morgan WJ
    Pediatr Pulmonol; 2020 Mar; 55(3):828-834. PubMed ID: 31746561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis.
    Solem CT; Vera-Llonch M; Liu S; Botteman M; Castiglione B
    Health Qual Life Outcomes; 2016 Apr; 14():63. PubMed ID: 27097977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis.
    Schultz A; McLeod C; Berry S; Marsh J; McKenzie A; Messer M; Wood J; Saville B; Jaffe A; Ranganathan S; Stick S; Wark P; Webb S; Snelling T
    Trials; 2023 Mar; 24(1):211. PubMed ID: 36949472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring indices predict poor FEV
    Pallin M; Kumar S; Daley C; Dawadi S; Leong P; Carr E; Soldatos G
    J Cyst Fibros; 2021 Sep; 20(5):785-791. PubMed ID: 33781701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment.
    Cogen JD; Sanders DB; Slaven JE; Faino AV; Somayaji R; Gibson RL; Hoffman LR; Ren CL
    Ann Am Thorac Soc; 2023 Sep; 20(9):1293-1298. PubMed ID: 37327485
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.
    VanDevanter DR; Heltshe SL; Spahr J; Beckett VV; Daines CL; Dasenbrook EC; Gibson RL; Raksha J; Sanders DB; Goss CH; Flume PA;
    J Cyst Fibros; 2017 Sep; 16(5):607-615. PubMed ID: 28438499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis.
    Wagener JS; Williams MJ; Millar SJ; Morgan WJ; Pasta DJ; Konstan MW
    J Cyst Fibros; 2018 Jul; 17(4):496-502. PubMed ID: 29685810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis.
    Nash EF; Choyce J; Carrolan V; Justice E; Shaw KL; Sitch A; Mistry H; Whitehouse JL
    Ther Adv Respir Dis; 2022; 16():17534666211070133. PubMed ID: 35274585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Reported Outcome Measures for Symptom Perception During a Cystic Fibrosis Exacerbation.
    Schmid-Mohler G; Caress AL; Spirig R; Benden C; Yorke J
    Respir Care; 2018 Mar; 63(3):353-366. PubMed ID: 29317460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysis.
    Gill ER; Dill C; Goss CH; Sagel SD; Wright ML; Horner SD; Zuñiga JA
    J Cyst Fibros; 2024 Nov; 23(6):1106-1111. PubMed ID: 38851922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial.
    Choyce J; Shaw KL; Sitch AJ; Mistry H; Whitehouse JL; Nash EF
    BMC Pulm Med; 2017 Jan; 17(1):22. PubMed ID: 28114922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
    West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
    J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.